A5038168777- Intracerebral and Subarachnoid Hemorrhage Research
- Retinoids in leukemia and cellular processes
- Protein Tyrosine Phosphatases
- Synthesis and biological activity
- Traumatic Brain Injury and Neurovascular Disturbances
- Ubiquitin and proteasome pathways
- Hepatocellular Carcinoma Treatment and Prognosis
- Chronic Kidney Disease and Diabetes
- Redox biology and oxidative stress
- Cerebrovascular and Carotid Artery Diseases
- Cancer Mechanisms and Therapy
- Nanoplatforms for cancer theranostics
- Neurosurgical Procedures and Complications
- Acute Ischemic Stroke Management
- Glycosylation and Glycoproteins Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Autophagy in Disease and Therapy
- Endoplasmic Reticulum Stress and Disease
- Cancer, Hypoxia, and Metabolism
Fudan University
2024
Zhongshan Hospital
2024
Wenzhou Medical University
2024
First Affiliated Hospital of Wenzhou Medical University
2024
The George Institute for Global Health
2016
The University of Sydney
2016
Current embolic agents in transcatheter arterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) encounter instability and easy leakage, discounting TACE efficacy with residual HCC. Moreover, clinical aggravates hypoxia pro-metastatic microenvironments, rendering patients HCC poor prognosis.
Abstract Intrahepatic cholangiocarcinoma (ICC) is a highly lethal malignancy that currently lacks effective clinical treatments. Eliminating stem cell‐like cancer cells an extremely promising but challenging strategy for treating ICC. A recently developed synthetic retinoid, sulfarotene, abrogates proliferation, and induces apoptosis of tumor‐repopulating (TRCs) exhibit properties, yet its effect underlying mechanisms remain elusive in It found although 5‐fluorouracil, cisplatin,...